Human epidermal growth factor (hEGF) is a polypeptide composed of 53 amino acid residues that is capable of eliciting a mitogenic response from a variety of epithelial and mesenchymal cells upon specific and high-affinity binding to its cell surface receptor (10) . Much is known about the structure of EGF (11, 12, 23, 29) , the EGF receptor (7, 11, 18) , and the cellular and organismal responses mediated by EGF addition (7, 10) . Other EGF-like molecules capable of high-affinity binding to the EGF receptor and stimulating the mitogenic response have also been identified. These include transforming growth factor alpha (TGF-oa; 14) , amphiregulin (36) , and several proteins from the poxvirus family, including the vaccinia virus growth factor (VGF; 39) , the Shope fibroma virus growth factor (SFGF; 26) , and the myxoma virus growth factor (MGF; 40) . The sequences of these various EGF and EGF-like molecules, in which the cysteines are aligned for maximum homology, are shown in Fig.  1 . Although the proteins do not exhibit a high degree of absolute sequence homology (-20%), they do contain a general consensus sequence, X5s45CX7CX2-3GXCX1013 CXCX3YXGXRCXn, in which the relative positions of the six cysteine residues and other highly conserved residues in the primary sequence are preserved.
The disulfide bond arrangements for EGF (34) , TGF-a (43) , and SFGF (26) have all been shown to be identical in that cysteines 6 and 20, 14 and 31, and 33 and 42 (EGF numbering system) pair to form three internal disulfide bonds that define three loop regions in these molecules. Although the disulfide patterns of amphiregulin, VGF, and MGF have not been elucidated, they are all assumed to be analogous to the EGF pattern. Of the three regions defined by these disulfide bridges, the third disulfide loop (also known as loop C) encompasses the most highly conserved region in all of these molecules. Five of the ten amino acid * Corresponding author. residues that comprise loop C are absolutely conserved; two of these are the cysteines that define the loop, the others being Tyr-37, Gly-39, and Arg-41 (EGF numbering system; Fig. 1 ). The uncompromising preservation of these residues at these positions suggests conservation for structural and/or functional reasons.
Using synthetic peptides corresponding to the various loops of rat TGF-a, Nestor et al. (30) showed that a peptide fragment corresponding to loop C was slightly active in EGF receptor binding (0.2% that of intact EGF), whereas fragments corresponding to other regions of TGF-a were inactive. However, similar work by Komoriya et al. (24) with synthetic peptide fragments of mouse EGF and by DefeoJones et al. (13) with synthetic peptide fragments from human TGF-a showed no ability for loop C fragments to bind to the EGF receptor.
In an effort to understand the role of loop C residues in EGF activity, our group has used site-directed mutagenesis to selectively alter several of these highly conserved residues in an intact molecule of EGF. In a previous report from our laboratory (17), we presented preliminary evidence indicating that the tyrosine at position 37 NSDSE  NSYPG  NSNTG  QDAPG  VVSHFND  VVSHFNK  NRKKKNP  DIPAIRL  IIKRIKL  IVLHVKV vC   vC  vC  vC   TC  TC   EC   DC   TC   TC   30 MYI (4) or by ion exchange on high-performance liquid chromatography (HPLC), using a Waters Gen-Pak FAX column (38) .
hEGF mutagenesis. The synthetic hEGF genetic construct used as a template was cloned into M13mpl9 DNA and has already been described (16) . hEGF mutants were generated by modifications of the single-primer extension method (44) as previously described (16, 31, 32) . All mutant hEGF constructions were verified by appropriate restriction endonuclease digestion, and the entire hEGF coding region was sequenced by the dideoxy-chain termination method (33) to verify the authenticity of the desired mutation as well as the absence of any undesired genetic alterations.
Expression and purification of wild-type and mutant hEGF proteins. The procedures for expression and purification of wild-type and mutant proteins were as described previously (16, 17) . Protein concentrations were based on the sample A280. Wild-type hEGF exhibits an t280 of 14,100 M-1 cm-' (15) .
EGF receptor binding and protein-tyrosine kinase assays. Radioreceptor competition binding assays measuring the specific binding of EGF proteins to the EGF receptor were carried out as described previously (8) (17) showed that a conservative substitution of phenylalanine for Tyr-37 resulted in a mutant EGF that had a receptor affinity slightly greater than that of the wild type. Other data from that same report showed that a semiconservative substitution in which a histidine residue and a nonconservative substitution in which an alanine residue were individually substituted for Tyr-37 resulted in mutant EGF molecules which also retained significant EGF receptor binding capability. However, recent reports (13, 25) from other laboratories employing site-directed mutagenesis at the presumed analogous tyrosine residue in loop C of TGF-a (Tyr-38) had indicated that an aromatic residue at this position in TGF-a was essential for its ability to bind to the EGF receptor. This apparent incongruity may suggest that although EGF and TGF-a recognize and bind to the same cell surface receptor (27) , they may do so in a dissimilar manner (17) . This report substantiates that a tyrosine at position 37 in EGF is not obligatory for receptor binding or further activation of the EGF receptor in stimulating the biological responses necessary for growth factor-induced mitogenesis.
Four additional mutant EGF molecules with nonconservative substitutions at position 37 were characterized for their ability to bind to the EGF receptor, to stimulate the EGF receptor's intrinsic tyrosine kinase activity, and to induce the incorporation of thymidine into newly synthesized DNA in mouse fibroblasts. The three position 37 mutant EGF molecules that had previously been characterized with respect to their receptor affinities (Phe-37, His-37, and Ala-37) were also further characterized for their ability to stimulate the protein kinase activity of the EGF receptor and ability to stimulate mitogenesis in quiescent fibroblasts.
The series of mutations introduced in the EGF molecule at position 37 represented amino acids with various side chains exhibiting a range of chemical functionality. Since all of these substitutions resulted in mutant EGF species that were still able to bind to the EGF receptor, we have concluded that a tyrosine at position 37 is not a requisite for direct chemical interaction with the EGF receptor. As a further test of the validity of this conclusion, the mutant EGFs were tested for their ability to stimulate the intrinsic tyrosine kinase activity of the EGF receptor; as shown, each was effective. The ability of each mutant to stimulate the kinase activity of the receptor was measured as a function of the concentration of each mutant species needed to elicit a half-maximal response from the receptor preparation with respect to its ability to phosphorylate an exogenous substrate on tyrosine residues. The EC50 values for the various mutant species followed a trend which paralleled their IC50 values, indicating that each mutant species was able to stimulate the EGF receptor's tyrosine kinase activity to an extent that paralleled each mutant's ability to bind to the receptor. Although all mutant species were able to stimulate this response, the mutant proteins with the two lowest receptor affinities appeared to stimulate this activity to a somewhat lower maximal velocity, approximately 70% that of the wild type and the other mutant species. A similar although more pronounced effect has been seen before with other mutant EGF species (28) .
Given the ability of these mutant EGF proteins to bind to and stimulate the tyrosine kinase activity of the EGF receptor in both solubiized and membrane-bound forms, they were presumed to be mitogenically active as well. Their ability to stimulate DNA synthesis in intact, quiescent A31 fibroblasts was therefore tested. Each mutant EGF was able to stimulate the incorporation of [3H]thymidine into acidinsoluble material, supporting the hypothesis that tyrosine at position 37 is nonessential for maintenance of biological activity. However, the effectiveness of these mutants on tissue culture cells was more pronounced than indicated by the in vitro assays. All mutants stimulated [3H]thymidine incorporation to a level similar to the wild-type level. The general tendency for mutant proteins to follow the same trend as seen in the in vitro assays (i.e., Phe > His > Ser > Ala > Asp > Arg > Gly) was not readily apparent in this assay, except that arginine and glycine were distinctly the least active. The apparent differences in the ability of each mutant to stimulate activity in vitro versus in cultured cells may result from intrinsic differences among the assays being compared. In the in vitro situation, measurements are being made under conditions of equilibrium binding. In culture, EGF binds to the receptor and initiates numerous complex cellular events, including binding and dissociation at the individual receptors and internalization of the EGF receptorligand complex. It has been observed that binding of EGF to a small fraction of the total complement of EGF receptors is sufficient to stimulate global down-regulation of all EGF receptors (42) . The possibility that relatively few receptors need be occupied in intact cells, coupled with the extended period of time (22 h) for which the cells were exposed to EGF, may contribute to the explanation of the differences observed. It is possible that no significant difference in this cellular response was seen with the various mutant EGFs because of the relatively high affinity of these mutant proteins for the EGF receptor, particularly if only a low percentage of EGF receptors, on the order of 10 to 20% as seen in other studies (2, 19, 20, 41) , need to be occupied for a full mitogenic response. Since the incorporation of thymidine into newly synthesized DNA is a late event associated with mitogen-activated cells, it is perhaps not surprising that no differences would be observed with mutants able to retain greater than 10% of receptor affinity with respect to wildtype EGF. However, as illustrated by the Gly-37 and Arg-37 mutants, which retain only 5 to 10% of wild-type receptor affinity, molecules that are relatively poor binders in vitro are less capable of stimulating thymidine incorporation when administered to cells at the same dosage as the wild-type protein. It is only when greater amounts of these particular mutants are added to the cells that a sufficient number of receptors become occupied for the required amount of time for a full mitogenic response to be observed. To test this hypothesis, studies that address receptor occupancy levels and studies focusing on early mitogen-activated responses are under way with several of these mutant proteins.
One obvious difference between the in vitro and cultured cell conditions can be ruled out as a cause of the differences in the responses: the ionic strength. Receptor binding is assayed at low ionic strength, while the whole-cell assays are conducted at an ionic strength of -0.16 M. In a study of the thermodynamics of EGF and EGF receptor binding, Campion and Niyogi (6a) have shown that the affinities are not significantly influenced by differences in ionic strength in the range covered by the two assays described in this report.
Mutant proteins containing nonaromatic substitutions at position 37 were observed to exhibit altered reverse-phase chromatographic profiles upon final purification when compared with wild-type EGF profiles (data not shown). These altered elution profiles consisted of the peak of EGF activity that eluted at a retention time similar to that of wild-type EGF and multiple protein peaks with longer retention times relative to this peak. The late-eluting peaks represent misfolded EGF proteins that have rearrangements in their disulfide bonding patterns (our unpublished observations). The same propensity to misfold was not seen with mutants that retained aromaticity at position 37 (Phe-37 and His-37). This may signify that although the tyrosine at position 37 is not essential for receptor binding and stimulation by direct (21, 35) . The same degree of conservation between EGF-like molecules that actually bind the EGF receptor and those that do not is not maintained at another residue that has been shown to be essential for receptor binding and stimulation, namely Arg-41 (17, 17a) . Fine-structure analysis of several of these position 37 mutants with use of two-dimensional nuclear magnetic resonance spectrometry is now under way and should provide further insight as to the nature of this structural role.
